Federal Circuit Upholds Cancellation Of Patent Covering Antifungal Drug
WASHINGTON, D.C. — In a June 21 ruling, the Federal Circuit U.S. Court of Appeals found no error in findings by the Patent Trial and Appeal Board that eight claims of...To view the full article, register now.
Already a subscriber? Click here to view full article